Clinical trial
WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes
NCT00147758
Study timeline
Study start (unknown)2004-06-01Date precision: month
Registry last updated2012-01-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
Colesevelam hydrochlorideDRUG · verified · RxNorm: colesevelam hydrochloride
Sponsors & collaborators
Daiichi Sankyolead sponsor
Mapped research locations
HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1DallasTexas, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1San AntonioTexas, United States1ClevelandOhio, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00147758 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.